Intrinsic Imaging provides imaging core lab services in support of musculoskeletal clinical trials. Established and study-specific scoring systems, applied by our musculoskeletal radiologists alongside quantitative imaging methods, provide sponsors with objective measures of disease progression and therapeutic response in indications affecting the bones, joints, muscles, connective tissues and spine. Intrinsic Imaging brings this expertise to orthopedic implant and spinal device studies as well.
At Intrinsic Imaging, our Musculoskeletal Imaging division brings together more than 150 board-certified, fellowship-trained musculoskeletal radiologists with expertise across a broad spectrum of musculoskeletal conditions, including osteoarthritis, rheumatoid and inflammatory arthritis, ankylosing spondylitis, osteoporosis, muscular dystrophy, spinal muscular atrophy, and cartilage disorders. This expertise extends to bone healing and repair, orthopedic implants, and other degenerative, inflammatory, metabolic, neuromuscular, and structural diseases affecting the musculoskeletal system.
Intrinsic Imaging supports musculoskeletal endpoints across an extensive range of imaging technologies, including radiography, CT and quantitative CT (QCT), DXA, conventional and advanced MRI, kinetic MRI, metal artifact reduction imaging, nuclear imaging, and ultrasound. Our teams work closely with sponsors from protocol development and imaging charter design through regulatory-ready data delivery to qualify imaging sites, standardize positioning and acquisition, maintain image quality control, train and qualify readers on each scoring system, and conduct centralized independent review with adjudication and quantitative analysis.
By combining musculoskeletal subspecialty expertise with standardized acquisition, calibrated scoring, and reproducible quantitative assessment, Intrinsic Imaging helps sponsors control variability across imaging sites, equipment, readers, and longitudinal timepoints. This consistency provides the methodological rigor needed to detect subtle structural and functional changes in complex musculoskeletal clinical trials.